![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: KRT8 |
Gene summary for KRT8 |
![]() |
Gene information | Species | Human | Gene symbol | KRT8 | Gene ID | 3856 |
Gene name | keratin 8 | |
Gene Alias | CARD2 | |
Cytomap | 12q13.13 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | Q7L4M3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3856 | KRT8 | GSM4909280 | Human | Breast | Precancer | 3.07e-04 | 3.14e-01 | 0.0305 |
3856 | KRT8 | GSM4909285 | Human | Breast | IDC | 3.65e-59 | 7.53e-01 | 0.21 |
3856 | KRT8 | GSM4909291 | Human | Breast | IDC | 2.05e-28 | 6.34e-01 | 0.1753 |
3856 | KRT8 | GSM4909293 | Human | Breast | IDC | 3.88e-11 | 3.44e-01 | 0.1581 |
3856 | KRT8 | GSM4909294 | Human | Breast | IDC | 2.92e-37 | 4.24e-01 | 0.2022 |
3856 | KRT8 | GSM4909296 | Human | Breast | IDC | 8.40e-07 | 1.07e-01 | 0.1524 |
3856 | KRT8 | GSM4909297 | Human | Breast | IDC | 7.06e-75 | 7.08e-01 | 0.1517 |
3856 | KRT8 | GSM4909300 | Human | Breast | IDC | 3.47e-10 | 4.80e-01 | 0.0334 |
3856 | KRT8 | GSM4909301 | Human | Breast | IDC | 1.23e-09 | 3.13e-01 | 0.1577 |
3856 | KRT8 | GSM4909302 | Human | Breast | IDC | 2.72e-10 | 3.21e-01 | 0.1545 |
3856 | KRT8 | GSM4909303 | Human | Breast | IDC | 3.68e-02 | 3.43e-01 | 0.0438 |
3856 | KRT8 | GSM4909304 | Human | Breast | IDC | 2.57e-26 | 5.01e-01 | 0.1636 |
3856 | KRT8 | GSM4909305 | Human | Breast | IDC | 7.13e-13 | 4.41e-01 | 0.0436 |
3856 | KRT8 | GSM4909306 | Human | Breast | IDC | 6.93e-29 | 5.15e-01 | 0.1564 |
3856 | KRT8 | GSM4909308 | Human | Breast | IDC | 3.98e-06 | 3.00e-01 | 0.158 |
3856 | KRT8 | GSM4909309 | Human | Breast | IDC | 2.12e-09 | 2.98e-01 | 0.0483 |
3856 | KRT8 | GSM4909311 | Human | Breast | IDC | 6.80e-40 | -1.29e-01 | 0.1534 |
3856 | KRT8 | GSM4909312 | Human | Breast | IDC | 4.93e-11 | 1.30e-01 | 0.1552 |
3856 | KRT8 | GSM4909313 | Human | Breast | IDC | 4.10e-07 | 2.21e-01 | 0.0391 |
3856 | KRT8 | GSM4909315 | Human | Breast | IDC | 1.26e-13 | 2.94e-01 | 0.21 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000110110 | Esophagus | ESCC | response to acid chemical | 84/8552 | 135/18723 | 7.70e-05 | 5.74e-04 | 84 |
GO:007135620 | Esophagus | ESCC | cellular response to tumor necrosis factor | 132/8552 | 229/18723 | 1.69e-04 | 1.11e-03 | 132 |
GO:00485687 | Esophagus | ESCC | embryonic organ development | 228/8552 | 427/18723 | 7.28e-04 | 3.79e-03 | 228 |
GO:00972847 | Esophagus | ESCC | hepatocyte apoptotic process | 13/8552 | 16/18723 | 4.05e-03 | 1.62e-02 | 13 |
GO:003103219 | Esophagus | ESCC | actomyosin structure organization | 108/8552 | 196/18723 | 4.86e-03 | 1.88e-02 | 108 |
GO:00607065 | Esophagus | ESCC | cell differentiation involved in embryonic placenta development | 18/8552 | 25/18723 | 7.04e-03 | 2.56e-02 | 18 |
GO:19040197 | Esophagus | ESCC | epithelial cell apoptotic process | 68/8552 | 121/18723 | 1.27e-02 | 4.21e-02 | 68 |
GO:00310326 | Liver | NAFLD | actomyosin structure organization | 41/1882 | 196/18723 | 4.26e-06 | 1.66e-04 | 41 |
GO:1904019 | Liver | NAFLD | epithelial cell apoptotic process | 24/1882 | 121/18723 | 8.75e-04 | 1.07e-02 | 24 |
GO:00971917 | Liver | NAFLD | extrinsic apoptotic signaling pathway | 36/1882 | 219/18723 | 2.14e-03 | 2.08e-02 | 36 |
GO:00972843 | Liver | NAFLD | hepatocyte apoptotic process | 6/1882 | 16/18723 | 3.37e-03 | 2.93e-02 | 6 |
GO:009719112 | Liver | Cirrhotic | extrinsic apoptotic signaling pathway | 97/4634 | 219/18723 | 1.82e-10 | 9.11e-09 | 97 |
GO:00017015 | Liver | Cirrhotic | in utero embryonic development | 134/4634 | 367/18723 | 2.78e-07 | 6.86e-06 | 134 |
GO:003103212 | Liver | Cirrhotic | actomyosin structure organization | 74/4634 | 196/18723 | 3.39e-05 | 4.17e-04 | 74 |
GO:00018905 | Liver | Cirrhotic | placenta development | 57/4634 | 144/18723 | 5.74e-05 | 6.58e-04 | 57 |
GO:00346126 | Liver | Cirrhotic | response to tumor necrosis factor | 89/4634 | 253/18723 | 1.24e-04 | 1.22e-03 | 89 |
GO:00011013 | Liver | Cirrhotic | response to acid chemical | 52/4634 | 135/18723 | 2.65e-04 | 2.36e-03 | 52 |
GO:00713566 | Liver | Cirrhotic | cellular response to tumor necrosis factor | 79/4634 | 229/18723 | 5.68e-04 | 4.45e-03 | 79 |
GO:00018925 | Liver | Cirrhotic | embryonic placenta development | 34/4634 | 82/18723 | 6.36e-04 | 4.85e-03 | 34 |
GO:009728411 | Liver | Cirrhotic | hepatocyte apoptotic process | 10/4634 | 16/18723 | 1.51e-03 | 9.91e-03 | 10 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KRT8 | SNV | Missense_Mutation | rs764622352 | c.1135G>A | p.Ala379Thr | p.A379T | P05787 | protein_coding | tolerated(0.15) | benign(0.012) | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
KRT8 | SNV | Missense_Mutation | rs770608691 | c.1081N>T | p.Ala361Ser | p.A361S | P05787 | protein_coding | tolerated(0.06) | possibly_damaging(0.897) | TCGA-S3-AA17-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | anastrozole | SD |
KRT8 | SNV | Missense_Mutation | novel | c.1249N>A | p.Ala417Thr | p.A417T | P05787 | protein_coding | tolerated(0.09) | benign(0.089) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
KRT8 | SNV | Missense_Mutation | rs764622352 | c.1135N>A | p.Ala379Thr | p.A379T | P05787 | protein_coding | tolerated(0.15) | benign(0.012) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
KRT8 | SNV | Missense_Mutation | novel | c.731N>C | p.Gly244Ala | p.G244A | P05787 | protein_coding | tolerated(0.34) | possibly_damaging(0.652) | TCGA-AA-3980-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
KRT8 | SNV | Missense_Mutation | novel | c.418N>A | p.Leu140Met | p.L140M | P05787 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
KRT8 | SNV | Missense_Mutation | c.314T>G | p.Val105Gly | p.V105G | P05787 | protein_coding | deleterious(0.02) | benign(0) | TCGA-CM-4744-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
KRT8 | SNV | Missense_Mutation | c.1087N>G | p.Ile363Val | p.I363V | P05787 | protein_coding | tolerated(0.09) | benign(0.098) | TCGA-EI-6882-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
KRT8 | SNV | Missense_Mutation | novel | c.705N>T | p.Lys235Asn | p.K235N | P05787 | protein_coding | deleterious(0) | benign(0.169) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
KRT8 | SNV | Missense_Mutation | rs752853262 | c.908G>A | p.Arg303Gln | p.R303Q | P05787 | protein_coding | tolerated(0.15) | benign(0.013) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |